(Q28199102)

https://api.crossref.org/works/10.1046/J.1472-8206.2003.00179.X

Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1472-8206.2003.00179.X

Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1472-8206.2003.00179.X

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

20 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Prophylactic aspirin and risk of peptic ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Safety and patient tolerance of standard and slow-release formulations of NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X

Comment on 'Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use' Tramer et al., Pain 2000;85:169-182

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00179.X